V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis

Sponsor
University of British Columbia
Study ID
NCT00175513
Phase
PHASE2
Status
Completed

Conditions

  • Psychosis

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an 18 week (2 weeks run-in, 16 weeks double blind) trial, to determine if an antiviral drug, valacyclovir (Valtrex) is helpful in treating the symptoms of psychosis, a form of a mental disorder.

Key Dates

Start date
Sep 30, 2005
Status verified
Apr 2011
Primary completion
Sep 30, 2009
Completion
Sep 30, 2009

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Related Studies